The Longevity Investor Network
The Longevity Investor Network (LIN) is a global initiative convened by the Lifespan Research Institute to catalyze private investment in biotechnology companies developing interventions that target the root mechanisms of aging. By mobilizing capital and fostering investor education, LIN supports the translation of cutting-edge science into therapies that extend human healthspan.
The network supports a diverse pipeline of companies addressing areas such as tissue regeneration, cellular reprogramming, senescence clearance, metabolic and mitochondrial health, neurodegeneration, and immune system rejuvenation.
Since its founding in 2020, the LIN has deployed over $5.5 million into promising biotechnology ventures and has grown into a trusted hub for longevity-focused deal flow and investor collaboration.
What We Offer
The LIN provides its members with a structured platform to discover, evaluate, and engage with longevity-focused startups through:
Curated monthly virtual pitch sessions featuring rigorously vetted early-stage companies
Educational seminars for investors on emerging areas in aging biology and biotech innovation
Collaborative diligence within a network of mission-aligned investors
Access to expert insights from leading scientists and translational research institutions
Our Process:
Past Seminars:
A Growing Portfolio of Rejuvenation Biotech Companies
Since 2020, the Longevity Investor Network has invested in 19 companies with over $5.5M in promising longevity startups worldwide. Our portfolio companies include:
A Program of Lifespan Research Institute
As a program of the Lifespan Research Institute, a nonprofit dedicated to advancing translational longevity science, the LIN reflects LRI’s commitment to accelerating real-world impact. Together, LRI and the LIN work to ensure that scientific breakthroughs in aging biology are not left on the shelf, but are actively translated into next-generation therapies for human benefit.
Apply to Join the Longevity Investor Network
If you are an accredited investor and are interested in joining the Longevity Investor Network, please fill out the form below and we’ll get back to you as quickly as possible. Thank you!
We are living through a remarkable turning point in biomedical history. The longevity biotechnology industry, once considered speculative, is now entering a phase of real-world traction. Investment is accelerating, driven by a new class of sophisticated funds and visionary investors who recognize both the economic potential and humanitarian promise of targeting the root causes of aging.
We’re seeing a wave of therapies in clinical trials, from senolytics to cellular reprogramming, inch closer to public availability. The pipeline is no longer theoretical—it’s operational. What was once science fiction is quickly becoming science fact, and the commercialization landscape is opening doors not just for patient impact, but for sustainable, scalable business models. It’s an incredibly exciting time to be part of this movement.
As the leader of the Longevity Investor Network, I’m thrilled to be doing my part to support and accelerate this progress. If you’re passionate about investing in early-stage startups shaping the future of healthspan and lifespan, I warmly invite you to reach out and join our growing investment community.
If you have additional questions about joining the Longevity Investor Network:
Get In Touch
